A novel small molecule METTL3 inhibitor exerts promising antitumor effects on oral squamous cell carcinoma

被引：0
|
作者：
Arumugam, P. [1 ]
Jayaseelan, V. P. [2 ]
机构：
[1] Saveetha Inst Med & Tech Sci, Mol Biol, Chennai, Tamil Nadu, India
[2] Saveetha Inst Med & Tech Sci, Clin Genet, Chennai, Tamil Nadu, India
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.01.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14P
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [41] Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects
    Huang, Tse-Hung
    Mokgautsi, Ntlotlang
    Huang, Yan-Jiun
    Wu, Alexander T. H.
    Huang, Hsu-Shan
    CELLS, 2021, 10 (08)
  • [42] M335, a novel small-molecule STING agonist activates the immune response and exerts antitumor effects
    Zhao, Man
    Fan, Weizhen
    Wang, Ying
    Qiang, Pengfei
    Zheng, Zhihua
    Shan, Hao
    Zhang, Ming
    Liu, Pengyutian
    Wang, Yao
    Li, Guofeng
    Li, Min
    Hong, Liang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 264
  • [43] Small molecule inhibitor of Stat3 induces antitumor cell effects in vitro and antitumor effects in vivo against human glioma or breast cancer model
    Yue, Peibin
    Lopez-Tapia, Francisco
    Tius, Marcus
    Turkson, James
    CANCER RESEARCH, 2014, 74 (19)
  • [44] Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma
    Zhou, Xiaoyi
    Jin, Wenke
    Chen, Yanmei
    Zhu, Lingjuan
    Mo, Anchun
    Xie, Qiang
    PHARMACOGENETICS AND GENOMICS, 2022, 32 (04): : 125 - 137
  • [45] Effects of fibroblast growth inhibitor on proliferation, metastasis and invasion of oral squamous cell carcinoma
    Noguchi, N
    Kawashiri, S
    Kato, K
    Nakaya, H
    Yamamoto, E
    ORAL ONCOLOGY, 2005, 1 (01) : 152 - 153
  • [46] Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines
    Harada, Koji
    Ferdous, Tarannum
    Kobayashi, Hiroaki
    Ueyama, Yoshiya
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (06) : 2439 - 2445
  • [47] MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells
    Liu, Tengfei
    Guan, Fangxia
    Wang, Yaping
    Zhang, Zhenkun
    Li, Ya
    Cui, Yuanbo
    Li, Zhe
    Liu, Hongtao
    Zhang, Yanting
    Wang, Yuming
    Ma, Shanshan
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 395
  • [48] Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma
    Michmerhuizen, Nicole L.
    Ludwig, Megan L.
    Birkeland, Andrew C.
    Nimmagadda, Sai
    Zhai, Jingyi
    Wang, Jiayu
    Jewell, Brittany M.
    Genouw, Dylan
    Remer, Lindsay
    Kim, Daniel
    Foltin, Susan K.
    Bhangale, Apurva
    Kulkarni, Aditi
    Bradford, Carol R.
    Swiecicki, Paul L.
    Carey, Thomas E.
    Jiang, Hui
    Brenner, J. Chad
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (05): : 1192 - 1205
  • [49] The Small Molecule Inhibitor QLT0267 Radiosensitizes Squamous Cell Carcinoma Cells of the Head and Neck
    Eke, Iris
    Leonhardt, Franziska
    Storch, Katja
    Hehlgans, Stephanie
    Cordes, Nils
    PLOS ONE, 2009, 4 (07):
  • [50] METTL3 mediated m6A modification plays an oncogenic role in cutaneous squamous cell carcinoma by regulating ΔNp63
    Zhou, Renpeng
    Gao, Ya
    Lv, Dongze
    Wang, Chen
    Wang, Danru
    Li, Qingfeng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (02) : 310 - 317
12345